Abvc Biopharma Inc (ABVC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2010 | 06-2010 | 03-2010 | 12-2009 | 09-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,900 | N/A | N/A | N/A | -5,180 |
| Depreciation Amortization | 40 | N/A | N/A | N/A | 40 |
| Other Working Capital | 130 | N/A | N/A | N/A | 70 |
| Other Operating Activity | 690 | 0 | 0 | 0 | 3,520 |
| Operating Cash Flow | $-1,040 | $N/A | $N/A | $N/A | $-1,550 |
| Cash Flows From Investing Activities | |||||
| Other Investing Activity | -10 | 0 | 0 | 0 | -50 |
| Investing Cash Flow | $-10 | $N/A | $N/A | $N/A | $-50 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 1,060 | 0 | 0 | 0 | 640 |
| Financing Cash Flow | $1,060 | $N/A | $N/A | $N/A | $640 |
| Beginning Cash Position | 0 | N/A | N/A | N/A | 970 |
| End Cash Position | 3 | N/A | N/A | N/A | 0 |
| Net Cash Flow | $3 | $N/A | $N/A | $N/A | $-970 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,040 | N/A | N/A | N/A | -1,550 |
| Free Cash Flow | -1,040 | 0 | 0 | 0 | -1,550 |